• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阻塞性肺疾病患者支气管扩张试验后的肺量计指标

Spirometric indices after bronchodilator test in obstructive lung disease.

作者信息

Mehrparvar Amir Houshang, Mirmohammadi Seyed Jalil, Sohrabi Mohammad Mehdi

机构信息

Department of Occupational Medicine, Shahid Rahnamoun Hospital, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.

出版信息

Acta Med Iran. 2010 Jul-Aug;48(4):226-30.

PMID:21279934
Abstract

Bronchial responsiveness to bronchodilator medications is usually tested to establish reversibility of airflow obstruction. Among the various tests to establish bronchodilator response, FEV1, FEF(25-75%) or FEF50%, and FVC are the most widely used. In a cross-sectional study, we assessed spirometric responses after administration of bronchodilator in 187 workers with obstructive pattern in spirometry. Considering responsiveness to bronchodilator (200 cc and 12% increase in FEV1 or FVC), the study cases were divided into responsive or non-responsive groups, and the average increase in spirometric indices were measured and compared between two groups. 35.8% of cases were responsive to bronchodilator. Among responsive cases, FEV1 was the most frequent index increased significantly; And PEF and FVC were the least frequent ones. The highest mean increase from baseline after administration of bronchodilator was observed in FEF75%. Increases in all indices were significantly higher in responsive group. The increase in FEV1% predicted was inversely correlated with baseline FEV1. In conclusion, we consider that FEV1 is the most reliable spirometric index for assessing bronchodilator response. And Bronchial reversibility has an inverse relationship with baseline measures.

摘要

通常会测试支气管对支气管扩张剂药物的反应性,以确定气流阻塞的可逆性。在各种用于确定支气管扩张剂反应的测试中,第一秒用力呼气容积(FEV1)、用力呼气流量(25%-75%)或用力呼气流量50%(FEF50%)以及用力肺活量(FVC)是使用最广泛的。在一项横断面研究中,我们评估了187名肺活量测定呈阻塞型的工人在使用支气管扩张剂后的肺量计反应。根据对支气管扩张剂的反应性(FEV1或FVC增加200毫升及12%),将研究病例分为反应组或无反应组,并测量和比较两组肺量计指标的平均增加量。35.8%的病例对支气管扩张剂有反应。在有反应的病例中,FEV1是最常显著增加的指标;而呼气峰值流速(PEF)和FVC是最不常增加的指标。在用力呼气流量75%(FEF75%)中观察到使用支气管扩张剂后相对于基线的最高平均增加量。反应组中所有指标的增加均显著更高。预测的FEV1%增加与基线FEV1呈负相关。总之,我们认为FEV1是评估支气管扩张剂反应最可靠的肺量计指标。并且支气管可逆性与基线测量值呈反比关系。

相似文献

1
Spirometric indices after bronchodilator test in obstructive lung disease.阻塞性肺疾病患者支气管扩张试验后的肺量计指标
Acta Med Iran. 2010 Jul-Aug;48(4):226-30.
2
A hospital-based study on pulmonary function tests and exercise tolerance in patients of chronic obstructive pulmonary disease and other diseases.一项基于医院的关于慢性阻塞性肺疾病及其他疾病患者肺功能测试和运动耐量的研究。
J Indian Med Assoc. 2007 Oct;105(10):565-6, 568, 570 passim.
3
Response to bronchodilators.
Clin Chest Med. 1989 Jun;10(2):155-64.
4
Reversibility prediction of chronic airways flow limitation by a new simple spirometric parameter.通过一种新的简单肺量计参数预测慢性气道气流受限的可逆性
Int J Clin Pharmacol Ther Toxicol. 1983 May;21(5):263-5.
5
When should a reversibility test be performed on patients with early stages of asthma and normal spirometry?对于哮喘早期且肺功能正常的患者,应在何时进行可逆性试验?
J Asthma. 2008 Aug;45(6):479-83. doi: 10.1080/02770900802069125.
6
[Response of airflow to the administration of bronchodilator agents in patients with chronic obstructive lung disease or asthma].[慢性阻塞性肺疾病或哮喘患者气流对支气管扩张剂给药的反应]
Rev Hosp Clin Fac Med Sao Paulo. 1991 Jul-Aug;46(4):163-5.
7
Significant bronchodilator responsiveness and "reversibility" in a population sample.人群样本中显著的支气管扩张反应性和“可逆转性”。
COPD. 2010 Oct;7(5):323-30. doi: 10.3109/15412555.2010.510161.
8
The use of criteria for reversibility and obstruction to define patient groups for bronchodilator trials. Influence of clinical diagnosis, spirometric, and anthropometric variables.使用可逆性和阻塞性标准来定义支气管扩张剂试验的患者组。临床诊断、肺量计和人体测量学变量的影响。
Am Rev Respir Dis. 1985 Oct;132(4):858-64. doi: 10.1164/arrd.1985.132.4.858.
9
Comparison of bronchodilator responsiveness in asthma and chronic obstructive pulmonary disease.哮喘与慢性阻塞性肺疾病中支气管扩张剂反应性的比较。
Indian J Chest Dis Allied Sci. 2002 Apr-Jun;44(2):91-7.
10
Spirometry in an unselected group of 6-year-old children: the DARC birth cohort study.未筛选的6岁儿童群体的肺活量测定:DARC出生队列研究
Pediatr Pulmonol. 2008 Aug;43(8):806-14. doi: 10.1002/ppul.20871.

引用本文的文献

1
Bronchodilator Response of FEV6 and FEV3 as Surrogates of Forced Vital Capacity.作为用力肺活量替代指标的FEV6和FEV3的支气管扩张剂反应
Tanaffos. 2014;13(1):20-5.
2
Assessment of bronchodilator response in various spirometric patterns.不同肺量计模式下支气管扩张剂反应的评估。
Tanaffos. 2013;12(2):28-33.